30542635|t|Pregabalin-associated Discontinuation Symptoms: A Case Report.
30542635|a|Pregabalin is used for the treatment of neuropathic pain, partial seizures, generalized anxiety disorder, social anxiety disorder, and insomnia. The discontinuation symptoms of pregabalin are mild to moderate which resolve in about one week after the discontinuation of pregabalin. This case report describes the withdrawal symptoms in a 62-year-old patient despite a slow titration over a period of several weeks. It highlights the importance of cautious monitoring of withdrawal symptoms during the period of taper.
30542635	0	10	Pregabalin	Chemical	MESH:D000069583
30542635	22	37	Discontinuation	Disease	
30542635	63	73	Pregabalin	Chemical	MESH:D000069583
30542635	103	119	neuropathic pain	Disease	MESH:D009437
30542635	129	137	seizures	Disease	MESH:D012640
30542635	139	167	generalized anxiety disorder	Disease	MESH:C000726808
30542635	169	192	social anxiety disorder	Disease	MESH:D000072861
30542635	198	206	insomnia	Disease	MESH:D007319
30542635	212	227	discontinuation	Disease	
30542635	240	250	pregabalin	Chemical	MESH:D000069583
30542635	314	329	discontinuation	Disease	
30542635	333	343	pregabalin	Chemical	MESH:D000069583
30542635	376	395	withdrawal symptoms	Disease	MESH:D013375
30542635	413	420	patient	Species	9606
30542635	533	552	withdrawal symptoms	Disease	MESH:D013375
30542635	Positive_Correlation	MESH:D000069583	MESH:D013375
30542635	Negative_Correlation	MESH:D000069583	MESH:D009437
30542635	Negative_Correlation	MESH:D000069583	MESH:D000072861
30542635	Negative_Correlation	MESH:D000069583	MESH:D012640
30542635	Negative_Correlation	MESH:D000069583	MESH:D007319
30542635	Negative_Correlation	MESH:D000069583	MESH:C000726808

